NewsRx

Search our medical news database

DPT Vaccine

Diphtheria dTpa or DTPa antibody protection rates similar after 10 years

Published in TB and Outbreaks Week, March 1st, 2005

A mathematical model indicates that anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa.

According to recent research published in the journal Vaccine, "The reduced antigen content diphtheria, tetanus, and pertussis (dTpa) vaccine (Boostrix) has been shown to induce a strong booster response to all the vaccine components in 4- to 6-year-olds. However, anti-diphtheria antibody levels were observed to be lower when compared to the 'full strength' pediatric DTPa vaccine. To assess the impact of this difference on long-term protection, a mathematical model was developed to predict diphtheria antibody decay over...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook